FS
Faysal A. Sohail

Faysal A. Sohail insider trades: Menlo Therapeutics (MNLO) stock buys and sales

Menlo Therapeutics Last trade Jul 24, 2018 12 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2013
4
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Faysal reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 24, 2018MNLO↓ Sell$3.7M
Jul 24, 2018MNLO↓ Sell$96K
Apr 20, 2016NEOS↓ Sell$198K
Apr 20, 2016NEOS↓ Sell$5K
Apr 15, 2016NEOS↓ Sell$578K
Apr 15, 2016NEOS↓ Sell$15K
Nov 10, 2014IMI↓ Sell$9.9M
Mar 20, 2014IMI↓ Sell$125K
Sep 18, 2013TTPH↓ Sell$1.0M
Sep 17, 2013TTPH↓ Sell$495K
Mar 25, 2013TTPH↑ Buy$4.5M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Faysal A. Sohail's insider trades

Faysal A. Sohail is an insider at Menlo Therapeutics (MNLO). Since Mar 25, 2013, Faysal has reported 1 open-market purchase worth $4.5M and 10 sales worth $16.1M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include conversions (4 filings), other transactions (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MNLO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.